![Narges Baniasadi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Narges Baniasadi
Private Equity Investor chez
Think+ Ventures Management LLC
Profil
Narges Baniasadi was the founder of Bina Technologies, Inc. which was founded in 2011 where she held the title of Chief Executive Officer from 2011 to 2016.
She currently holds a position as Venture Partner at Think+ Ventures Management LLC.
Ms. Baniasadi has held several former positions including Director at BioBeats Group Ltd. and Base Genomics Ltd. from 2019 to 2020, Vice President and Life Cycle Leader at F.
Hoffmann-La Roche Ltd. from 2015 to 2018, and Venture Partner at Entrepreneur First Operations Ltd. in 2019.
She also has an education background with graduate and doctorate degrees from Stanford University.
Postes actifs de Narges Baniasadi
| Sociétés | Poste | Début |
|---|---|---|
Think+ Ventures Management LLC
 Think+ Ventures Management LLC Investment ManagersFinance Think+ Ventures invests in companies located in the United States. The firm targets companies operating on a broad range of sectors and industries. It participates in seed and early stage capital transactions with an investment size of USD 0.2 - 0.5 million. It makes follow-on investments. | Private Equity Investor | - |
Anciens postes connus de Narges Baniasadi
| Sociétés | Poste | Fin |
|---|---|---|
Base Genomics Ltd.
 Base Genomics Ltd. Medical SpecialtiesHealth Technology Develops a blood test for early-stage cancer and minimal residual disease | Directeur/Membre du Conseil | 30/11/2020 |
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises invests in companies located in the United Kingdom. The firm targets companies operating in the fields of health tech, deep tech, and life sciences sectors. It provides financing for seed and early stage capital requirements with an investment size of GBP 0.1 – 10 million. | Private Equity Investor | 01/06/2020 |
BioBeats Group Ltd.
 BioBeats Group Ltd. Packaged SoftwareTechnology Services Designs and develops mobile software applications | Directeur/Membre du Conseil | 31/05/2020 |
Entrepreneur First Operations Ltd.
 Entrepreneur First Operations Ltd. Investment ManagersFinance Entrepreneur First Operations (EF) invests in companies located in the UK & Asia region. The firm focuses on aerospace, agriculture, AR/VR media, automotive, commerce, data analysis, digital health, education, energy, enterprise solution, finance, gaming, infrastructure/dev tool, legal, life science, manufacturing, property/real estate, robotics, security, space & transportation & technology sectors. They provide financing for seed and early stage transactions. It invests up to $100,000. It's geographical focus is mainly on Bangalore and Singapore. | Private Equity Investor | 31/12/2019 |
Entrepreneur First Operations Ltd.
Entrepreneur First Operations Ltd. Investment ManagersFinance Entrepreneur First Operations (EF) invests in companies located in the UK & Asia region. The firm focuses on aerospace, agriculture, AR/VR media, automotive, commerce, data analysis, digital health, education, energy, enterprise solution, finance, gaming, infrastructure/dev tool, legal, life science, manufacturing, property/real estate, robotics, security, space & transportation & technology sectors. They provide financing for seed and early stage transactions. It invests up to $100,000. It's geographical focus is mainly on Bangalore and Singapore. | Private Equity Investor | 01/12/2019 |
Formation de Narges Baniasadi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bina Technologies, Inc.
 Bina Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides platform accelerating and genomic analysis services | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioBeats Group Ltd.
BioBeats Group Ltd. Packaged SoftwareTechnology Services Designs and develops mobile software applications | Technology Services |
Entrepreneur First Operations Ltd.
Entrepreneur First Operations Ltd. Investment ManagersFinance Entrepreneur First Operations (EF) invests in companies located in the UK & Asia region. The firm focuses on aerospace, agriculture, AR/VR media, automotive, commerce, data analysis, digital health, education, energy, enterprise solution, finance, gaming, infrastructure/dev tool, legal, life science, manufacturing, property/real estate, robotics, security, space & transportation & technology sectors. They provide financing for seed and early stage transactions. It invests up to $100,000. It's geographical focus is mainly on Bangalore and Singapore. | Finance |
Oxford Science Enterprises PLC
Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises invests in companies located in the United Kingdom. The firm targets companies operating in the fields of health tech, deep tech, and life sciences sectors. It provides financing for seed and early stage capital requirements with an investment size of GBP 0.1 – 10 million. | Finance |
Think+ Ventures Management LLC
Think+ Ventures Management LLC Investment ManagersFinance Think+ Ventures invests in companies located in the United States. The firm targets companies operating on a broad range of sectors and industries. It participates in seed and early stage capital transactions with an investment size of USD 0.2 - 0.5 million. It makes follow-on investments. | Finance |
Base Genomics Ltd.
Base Genomics Ltd. Medical SpecialtiesHealth Technology Develops a blood test for early-stage cancer and minimal residual disease | Health Technology |
